Alzheimer's Disease & Dementia

Alzheimer Disease Biomarkers Expose Individuals to Long-Term Care Insurance Denial

Alzheimer Disease Biomarkers Expose Individuals to Long-Term Care Insurance Denial

Approximately 5.5 million Americans have Alzheimer disease or dementia.

Biomarkers of Alzheimer Disease Observed in Down Syndrome

Biomarkers of Alzheimer Disease Observed in Down Syndrome

Neurological and neuropsychological examinations were performed to assess intellectual disabilities, and biological assays were performed on collected CSF and plasma.

Exercise May Delay Symptoms of Alzheimer's in Those at Risk

Exercise May Delay Symptoms of Alzheimer's in Those at Risk

Findings among individuals with a genetic mutation known to cause Alzheimer's.

Prevalence of Alzheimer's, Related Dementia Set to Double

Prevalence of Alzheimer's, Related Dementia Set to Double

Alzheimer's disease and related dementias burden is expected to increase to 3.3% in 2060.

Age, Sex, <i>APOE</i> Genotype Identify Alzheimer's, Dementia Risk

Age, Sex, APOE Genotype Identify Alzheimer's, Dementia Risk

Three factors help identify absolute 10-year risk of Alzheimer's disease, all dementia for different groups.

Increased Levels of Human Herpesvirus Identified in Alzheimer's

Increased Levels of Human Herpesvirus Identified in Alzheimer's

Disruption of molecular, genetic, clinical networks by human herpesvirus in brains of subjects with AD.

Cognitive Impairment Profiles Differ Between Parkinson's, Alzheimer's

Cognitive Impairment Profiles Differ Between Parkinson's, Alzheimer's

By

As the neurodegenerative processes of Alzheimer disease and Parkinson disease are different, early cognitive impairment also present differently in these diseases.

New Clinical Guideline for Evaluating Alzheimer's, Related Dementias

New Clinical Guideline for Evaluating Alzheimer's, Related Dementias

By

Currently, there are no US consensus on best clinical practice guidelines that incorporate multispecialty recommendations for evaluating cognitive impairment that are thought to be due to Alzheimer's disease and Related Dementias (ADRD) for use by physicians and nurse practitioners.

Retinal Nerve Fiber Layer Thickness May Be Associated With Cognitive Function

Retinal Nerve Fiber Layer Thickness May Be Associated With Cognitive Function

By

Thinning of the retinal nerve fiber layer has been linked to worsening cognitive function and may be valuable in identifying individuals who may be at risk for cognitive decline.

Diagnosis, Treatments Affected by Amyloid Results in Dementia, Nondementia Patients

Diagnosis, Treatments Affected by Amyloid Results in Dementia, Nondementia Patients

By

In patients with and without dementia, amyloid-positive and negative results were significantly linked to diagnoses and treatment changes.

Genetic Risk Score Better Than APOE Alone for Assessing Risk for Alzheimer's Dementia

Genetic Risk Score Better Than APOE Alone for Assessing Risk for Alzheimer's Dementia

The genetic risk score primarily modified the risk for and onset of dementia and AD among homozygous carriers for APOE ε4.

Dementia, Alzheimer Disease Risk Increased With Lower Branched-Chain Amino Acid Levels

Dementia, Alzheimer Disease Risk Increased With Lower Branched-Chain Amino Acid Levels

By

Lower BCAA levels may be associated with an increased risk of incident dementia.

Excessive Daytime Sleepiness Linked to Elevated β-Amyloid Accumulation in Elderly Persons

Excessive Daytime Sleepiness Linked to Elevated β-Amyloid Accumulation in Elderly Persons

By

Elderly individuals without dementia who have elevated daytime sleepiness may be at greater risk for β-amyloid accumulation.

Trials for Investigational Alzheimer's Treatment Lanabecestat Discontinued

Trials for Investigational Alzheimer's Treatment Lanabecestat Discontinued

By

The independent data monitoring committee (IDMC) concluded that the 2 trials (AMARANTH and DAYBREAK-ALZ) investigating the treatment in mild Alzheimer's disease dementia, were not likely to meet their primary endpoints of change from baseline on the 13-item Alzheimer's Disease Assessment Scale - Cognitive Subscale.

Accumulation of Brain Pathologies Linked to Reduced Activity in Older Adults

Accumulation of Brain Pathologies Linked to Reduced Activity in Older Adults

Brain autopsies of participants of the Rush Memory Aging project (n=428) were studied to identify the association between brain pathologies and total daily physical activity and mortality.

Newly Proposed Definition of Alzheimer's Disease Focuses on Biologic Criteria

Newly Proposed Definition of Alzheimer's Disease Focuses on Biologic Criteria

By

The NIA-AA has proposed updates to the 2011 guidelines for symptomatic stages of Alzheimer's disease to include the idea that certain imaging and cerebrospinal fluid biomarkers are valid proxies for neuropathologic changes of AD.

Hip fracture risks increase with short-term PPI use in patients with Alzheimer's disease

Hip fracture risks increase with short-term PPI use in patients with Alzheimer's disease

Short-term proton pump inhibitors (PPIs) are linked to an elevated risk for hip fracture among patients with Alzheimer's disease. No link is seem among patients taking long-term or cumulative PPIs.

Solanezumab does not change cognitive decline in mild Alzheimer’s disease

In patients with mild Alzheimer's disease solanezumab, an antibody designed to facilitate clearance of amyloid-beta plaques, did not significantly reduce cognitive decline over time.

Higher education may help reduce Alzheimer's disease risk

Higher education may help reduce Alzheimer's disease risk

By

Attaining higher education may aid in the prevention of Alzheimer's disease.

Alzheimer's cases to increase to 15 million by 2060

Alzheimer's cases to increase to 15 million by 2060

Over 6 million Americans were diagnosed with Alzheimer's this year, which will increase to 15 million by 2060.

Sleep disorders may increase risk for Alzheimer's disease

Sleep disorders may increase risk for Alzheimer's disease

By

Obstructive sleep apnea and sleep-disordered breathing are associated with amyloid deposition.

Residing near busy roads increases risk for dementia

Residing near busy roads increases risk for dementia

Approximately 11% of dementia cases for people living within 164 feet of a major roadway might be attributed to this proximity to traffic.

Statins may reduce risk of Alzheimer's disease

Statins may reduce risk of Alzheimer's disease

By

Depending on race, sex, and ethnicity, the right statin type may lower the risk of Alzheimer disease.

Risk of Alzheimer dementia after androgen deprivation therapy

Risk of Alzheimer dementia after androgen deprivation therapy

By

A recent cohort study evaluated the risk of developing Alzheimer dementia after ADT in 16,888 men with prostate cancer, 14.2% of whom were treated with ADT.

The bravery of people with dementia

The bravery of people with dementia

By

Facing dementia with strength and courage can inspire and comfort patients' families.

Minimal benzodiazepine use associated with slightly higher risk of dementia

Minimal benzodiazepine use associated with slightly higher risk of dementia

By

Patients administered low doses of benzodiazepines have an elevated risk of dementia and Alzheimer's disease compared with patients who received higher doses.

Prostate cancer treatment linked to Alzheimer's risk

Prostate cancer treatment linked to Alzheimer's risk

By

Patients treated with androgen deprivation therapy had a 1.88-times increased rate of developing Alzheimer's disease.

Modifiable risk factors for Alzheimer's disease

Modifiable risk factors for Alzheimer's disease

By

Research reveals that focus on diet, mental health, and lifestyle may help lower the number of new cases of Alzheimer's disease.

MIND diet help may lower Alzheimer risk

MIND diet help may lower Alzheimer risk

The MIND diet combines the Mediterranean diet with the DASH diet, both of which call for high consumption of fruits, vegetables, and fish.

Running may lower Alzheimer-related mortality risk

Running may lower Alzheimer-related mortality risk

Patients who ran more than 15.3 miles per week had a 40% reduced risk of dying from Alzheimer disease.

Sign Up for Free e-newsletters